Tonix Pharmaceuticals Holding Corp. (TNXP) › Net IncomeTonix Pharmaceuticals Holding Corp. (TNXP) — Net IncomeAnnual figures by fiscal year, from SEC filings.2008: -$202.0K2009: -$221.0K2010: -$1.96M2011: -$3.47M2012: -$9.45M2013: -$10.88M2014: -$27.62M2015: -$48.05M2016: -$38.84M2017: -$21.12M2018: -$26.09M2019: -$28.62M2020: -$50.46M2021: -$92.29M2022: -$110.22M2023: -$116.66M2024: -$130.04M2025: -$124.02M-$124.02M2008Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$124.02M+4.6%2024-$130.04M-11.5%2023-$116.66M-5.8%2022-$110.22M-19.4%2021-$92.29M-82.9%2020-$50.46M-76.3%2019-$28.62M-9.7%2018-$26.09M-23.5%2017-$21.12M+45.6%2016-$38.84M+19.2%2015-$48.05M-74.0%2014-$27.62M-153.7%2013-$10.88M-15.2%2012-$9.45M-172.3%2011-$3.47M-76.7%2010-$1.96M-788.7%2009-$221.0K-9.4%2008-$202.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share